Skip to main content
GMRS logo

GMRS · GMR Solutions Inc.

Track GMRS — free
$10.12 +0.11 (+1.10%) At close · Nov 20
Market Cap
$674.99M
Shares
66.70M
Volume · Nov 20 955.59K Avg daily vol (3M) 1M

Price & Indicators

 

Key stats

Close
$10.12
Fri 20 Nov
Open
$10.14
Fri 20 Nov
Average volume, 30 days
1.0M
shares a session
Short interest
4.7M
7.1% of shares · 9.3 days to cover
Day range
$9.88$10.41
Open $10.14 Close $10.12
Available closing range
$9.42$15.74
Close $10.12 35.7% under the high
Short volume, last session
45%
Last earnings
Nov 10, 2026
Latest filing
10-Q · Nov 9
Price history
May 2026 to Nov 2026

The closing range uses available history since May 13, 2026; less than a full year is stored.

Up next

Jan 29, 2027 Est · unconfirmed · in 10 wks

Latest documents

2026
Nov 9
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly revenue rose 5.9% as net income jumped 81.7%

GMR Solutions Inc. reported revenue of $1,595.6 million, up 5.9%, and net income of $135.6 million, up 81.7%, for the three months ended September 30, 2026.

Revenue $1.6B ▲ 5.9% Net income $135.56M ▲ 81.7% Diluted EPS $0.56 ▲ 700.0%
Read from the MD&A section
Source passage
In the three months ended September 30, 2026, revenue increased by $88.7 million, or 5.9%, to $1,595.6 million year-over-year. In the three months ended September 30, 2026, net income increased by $61.0 million, or 81.7%, to $135.6 million year-over-year. Open the document at this passage
Nov 9
Current report 8-K
Third-quarter net income rises 81.7% as revenue grows 5.9%

GMR Solutions Inc. reported third-quarter revenue of $1,595.6 million, up 5.9%, and net income of $135.6 million, up 81.7%, through September 30, 2026. Full-year 2026 guidance: revenue of $5,900 million–$6,050 million and Adjusted EBITDA of $1,135 million–$1,195 million.

Financial results
4 source passages
GMR Solutions Inc. (“GMR” or the “Company”) (NYSE: GMRS), the nation’s largest provider of emergency medical services (“EMS”), today announced financial results for the three and nine months ended September 30, 2026, and updated its full year 2026 financial guidance. “We delivered strong financial performance in the third quarter, with revenue increasing 5.9% to $1,595.6 million, and net income increasing 81.7% to $135.6 million, despite weather-related pressure on flight activity, higher fuel and other inflationary costs, and the anticipated shift in payor mix,” said Brian Tierney, Chief Financial Officer. | Net revenue | | $ | 5,900 | | $ | 6,050 | | Adjusted EBITDA^(2)^ | | $ | 1,135 | | $ | 1,195 | Open the document at this passage
Sep 11
Current report 8-K
Other events AI summary on its way
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+5.9%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$3.89B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+63.4%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
7.1%
Latest settlement · 9.3 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 13, 2026
Q2 FY26

TL;DR. GMR Solutions reported Q2 2026 revenue up 3.3% to $1.49B with adjusted EBITDA down 11.8% to $284.5M (largely due to a $74M prior-year NSA estimate comp and ~$16M ACA exchange payer-mix headwind), a swing to a $28.3M net loss driven by $142.3M of IPO-related expenses, and reaffirmed full-year guidance while flagging continued Iran-conflict fuel/cost pressure.

Bullish
  • + Q2 revenue grew 3.3% YoY to $1,490.3M with continued momentum in emergent services
  • + Liquidity strengthened with $420M cash and ~$696M undrawn ABL capacity following IPO capital actions and credit rating upgrade
  • + Net leverage already at 3.5x (down from 4.3x) with line of sight to below 3.3x by year-end and 3.0x by end of 2027
  • + 911 Nurse Navigation scaled to 29 communities / 19.7M covered lives with calls up 50% YoY and four more implementations planned
Bearish
  • − Adjusted EBITDA fell 11.8% YoY to $284.5M as margin pressure from ACA exchange subsidy expiration and higher costs weighed on results
  • − Net loss of $28.3M in Q2 vs. $80.8M net income prior year, driven by $142.3M of IPO-related stock comp and professional fees
  • − Total operating expense rose 19.4% YoY to $1.43B, with employee wages up 24.5% and fuel/maintenance up 21.1% on Iran-conflict and aircraft maintenance timing
  • − CapEx and aircraft financing stepped up to 6.3% of revenue vs. 4.5% prior year due to pull-forward of purchases
  • − Year-over-year No Surprises Act/IDR revenue estimate tailwind was $74M lower, creating a meaningful comparability drag

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 35.9 · fear Equity put/call 0.77
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 50-day avg −8%
below
RSI (14) 40
neutral
MACD trend Negative
52-week position 11%
near low
Momentum
relative strength
Weak
1-month return −6%
trailing
6-month return −5%
trailing
Relative strength +5%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+31% holders QoQ · +36 funds added
Insider flow Distributing
Net -$29.8M over 90 days · 100% sells
Short interest Rising
7.08% of shares out · ▲ +5.0% MoM · 9.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
81 holders — 13F breadth
Squeeze score 66
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 65%
annualized · 1-yr
Max drawdown −40%
past year
ATR 7.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Aug 13, 2026
Revenue · full year $5.89B – $6.18B
Adjusted EBITDA · full year Non-GAAP $1.14B – $1.2B
Total cash used for CapEx and aircraft financing, % of total rev · full year 5.1% – 5.3%
Total cash used for CapEx and aircraft financing as a percent of · full year 5.1% – 5.3%
Total cash used for CapEx and aircraft financing · full year 5.1% – 5.3%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
3 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−8% Bearish
RSI (14)
40 Neutral
MACD trend
Negative Bearish
52-week position
11% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+31% holders QoQ · +36 funds added
Insider flow Distributing
Net -$29.8M over 90 days · 100% sells
Short interest Rising
7.08% of shares out · ▲ +5.0% MoM · 9.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
81 holders — 13F breadth
Price context
position in its available closing range
Range low $9 Now $10 · 11% Range high $16
vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Commercial insurance and managed care 57% Three Months Ended September 30, 2026 filing —
Medicaid 9% the three months ended September 30, 2026 filing —
Medicare 25% the three months ended September 30, 2026 filing —
Non-emergent transports 203,894 Three Months Ended September 30, 2026 filing —
Other third-party payors 8% Three Months Ended September 30, 2026 filing —
Self-pay 1% Three Months Ended September 30, 2026 filing —
net revenue per transport 7.9% the three months ended March 31, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GMRS
GMR Solutions Inc.
this stock
$674.99M — — — 7.1%
HCA
HCA Healthcare, Inc.
$99.34B +1.9% +7.1% 15.8 2.3%
FSNUY
Fresenius SE & Co. KGaA
$31.59B -2.2% — — 0.0%
THC
Tenet Healthcare Corp
$20.95B +32.4% +0.9% 7.6 2.2%
EHC
Encompass Health Corp
$13.11B +25.9% +10.5% 20.9 3.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
81
% held
82.0%
Net QoQ
+3.4M sh
Top holder
Kohlberg Kravis Roberts &…
Held Float
View
Held by Funds
Fund positions
33
View
Short & Settlement
Short Interest Rising
Shares short
4.7M
Days to cover
9.3d
Change
+224.3K sh
View
Short Volume
Short vol %
45%
As of
Nov 20, 2026
Short Total
View
Fails to Deliver
FTD shares
8.6K
Value
$91.7K
As of
Oct 28, 2026
View
Off-Exchange
Off-exchange %
44.4%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$29.8M
Buyers / Sellers
0 / 6
Buyers Sellers
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 9, 2026
This year
18

GMR Solutions Inc. reported revenue of $1,595.6 million, up 5.9%, and net income of $135.6 million, up 81.7%, for the three months ended September 30, 2026.

View
Proposed Sales
Value
$1.0M
Shares
90.0K
Filed
Nov 13, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Dec 1, 2026
Last webcast
Nov 10, 2026
View
Investor Relations
Latest news
GMR Solutions Inc. to Participate…
Published
Nov 18, 2026
Upcoming events
3
View

Performance

5D 20D 120D MTD YTD
GMRS -12.3% -5.7% -4.6% -9.6% —
SPY -8.6% -9.2% -9.2% -8.7% +1.2%
vs SPY -3.8% +3.6% +4.6% -0.8% —
Key facts CIK 1898718 CUSIP 38013D106 13F (30d) 79 filings 79 filers Visit website Investor relations